Nanobiotix S.A. Interest Expense 2011-2026 | NBTX

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Nanobiotix S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-4.68 M	4.43 M	847 K	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
4.43 M	-4.68 M	202 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	2.2 M	$ 8.67	0.35 %	$ 85.7 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.6	-1.64 %	$ 8.66 B	Australia
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
Anavex Life Sciences Corp. AVXL	4.68 M	$ 3.27	4.98 %	$ 279 M	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Brainstorm Cell Therapeutics BCLI	-93 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
BeiGene, Ltd. BGNE	-42.6 M	-	0.49 %	$ 251 B	Cayman-islands
BioNTech SE BNTX	14.2 M	$ 99.34	2.73 %	$ 27.2 B	Germany
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
Cabaletta Bio CABA	2 M	$ 3.23	0.94 %	$ 325 M	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 21.6	1.12 %	$ 1.01 B	USA
Checkpoint Therapeutics CKPT	344 K	-	-	$ 169 M	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	58 K	$ 1.54	4.76 %	$ 396 M	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.05	4.45 %	$ 5.02 M	Israel
Aquestive Therapeutics AQST	6.55 M	$ 4.21	0.36 %	$ 450 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 25.33	5.01 %	$ 3.22 B	USA
Chimerix CMRX	11 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	-309 K	-	-	$ 401 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	927 K	$ 33.59	3.07 %	$ 2.23 B	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.49	1.1 %	$ 397 M	Britain
Cidara Therapeutics CDTX	5.81 M	-	-	$ 1.41 B	USA
CNS Pharmaceuticals CNSP	7.03 K	$ 2.46	-1.99 %	$ 1.09 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
CTI BioPharma Corp. CTIC	13.1 M	-	-	$ 1.2 B	USA